新聞及資訊

Canada: Risk of inadvertent injection of Adrenalin™ (epinephrine chloride 1:1000) intended for topical use (English Only)
新聞及資訊


Erfa Canada Inc. in consultation with Health Canada informs health professionals of important safety information concerning an increased risk of inadvertent injection of topical/nasal Adrenalin™ 1 mg/mL (epinephrine chloride 1:1000) due to the similarity of its packaging to injectable use vials. Please refer to the following website in Health Canada for details: http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2010/adrenalin_hpc-cps-eng.php In Hong Kong, the above product is not registered and there is no topical/nasal epinephrine (adrenaline) preparation registered in Hong Kong. Ends/ Wednesday, August 19, 2010 Issued at HKT 15:00

新 聞 及 資 訊